National Institute of Health Director Francis Collins said Sunday that current coronavirus vaccines will "most likely" be effective against the omicron variant, but it is too soon to tell for sure.
Moderna CEO Stephane Bancel on Monday said it will take months to develop and ship a vaccine that specifically targets the omicron variant of the virus that causes Covid-19. However, a higher 100-microgram dose of the company’s booster shot could be ready much sooner.
The omicron variant of COVID-19 appears to be more infectious than the delta variant, and the high number of mutations on omicron means that all vaccines may be less effective, Moderna’s CEO said Monday. Stephane Bancel made the comments in an interview with CNBC.
Stéphane Bancel, the CEO of Moderna, said in an interview published Tuesday that current vaccines for COVID-19 will likely be much less effective against the new omicron variant.
The White House on Tuesday responded to concerns voiced by a Moderna executive who suggested the current vaccines slotted to fight the coronavirus will not be enough to counter the new omicron variant.
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impos…
Moderna's CEO predicted Tuesday that existing coronavirus vaccines would be much less effective at combating omicron compared with previous covid-19 variants, spooking financial markets in the United States, Europe and Asia as scientists rush to learn about the new variant.
Markets Drop As Moderna CEO Predicts Existing Covid-19 Vaccines Will Be Less Effective Against Omicron Variant | Since Then
